Anti-CCHFV Drug Discovery Products

Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a tick-borne virus that belongs to the Bunyaviridae family and Nairovirus genus. The CCHFV mainly infects humans and can cause severe hemorrhagic fever. CCHFV is a significant public health concern in many countries, with outbreaks occurring periodically. The virus is distributed widely across Africa, Asia, and Europe. The virus is distributed widely across Africa, Asia, and Europe. Currently, there is no specific treatment for CCHFV infection, and management is mainly focused on reducing symptoms and improving patient survival rates.

The viral genome encodes three structural proteins: the glycoprotein (G1), the glycoprotein (G2), and the nucleocapsid protein (N). The G1 and G2 proteins are involved in virus attachment to host cells and are critical for virus infection.

At Creative Biolabs, we provide researchers with a range of antibodies and reagents for studying Crimean-Congo Hemorrhagic Fever Virus.